Document:

Exhibit
10.1

 

AMENDED
AND RESTATED EMPLOYMENT AGREEMENT

 

This
AMENDED AND RESTATED EMPLOYMENT AGREEMENT (“Agreement”) is made effective as of December_8_, 2020, (the
“Effective Date”), by and between CONVERSION LABS, INC., a Delaware corporation (the “Company”),
and Nicholas Alvarez, an individual and resident of the State of California (the “Employee”). The Company and
Employee are hereinafter sometimes referred to collectively as the “Parties” and individually as a “Party.”

 

WlTNESSETH:

 

WHEREAS,
Employee is currently employed by the Company pursuant to an Employment Agreement (the “Original Employment Agreement”)
dated as of July 26, 2018, as amended on this Effective Date;

 

WHEREAS,
the Company agrees to continue to employ the Employee and the Employee agrees to continue to be employed by the Company on the
terms and conditions set forth therein.

 

NOW,
THEREFORE, for and in consideration of the mutual promises, covenants and obligations contained, the Company and Employee hereby
agree as follows:

 

1.
Employment and Location. The Company hereby employs Employee, and Employee hereby accepts employment by the Company, on
the terms and conditions hereinafter set forth.

 

2.
Duties and Responsibilities.

 

(a)
Position and Duties. Commencing as of the Effective Date, Employee shall serve in the position of Chief Acquisition Officer.
During the Employment Term, Employee shall (i) be subject to all of the Company’s policies, rules and regulations applicable
to its executives, (ii) report to, and be subject to the direction and control of, the Chief Executive Officer, and (iii) perform
such duties commensurate with Employee’s position as shall be assigned to Employee.

 

(b)
Standard of Performance. Employee agrees that he will at all times faithfully and industriously and to the best of his
ability, experience, and talents perform all the duties that may be required of and from him pursuant to the terms of this Agreement
and consistent with his position. Such duties shall be performed at such place or places as the interests, needs, business, and
opportunities of the Company shall reasonably require or render advisable.

 

(c)
Exclusive Service.

 

(i)
Employee shall devote substantially all of his business energies and abilities to the performance of his duties under this Agreement
(reasonable absences during holidays and vacations excepted), and shall not, without the prior written consent of the Company,
render to others any service of any kind (whether or not for compensation) that would materially interfere with the performance
of his duties under this Agreement, and

 

    	1

     

    

 

(ii)
Employee shall not, without the prior written consent of the Company, maintain any affiliation with, whether as an agent, consultant,
employee, officer, director, trustee or otherwise, nor shall he directly or indirectly render any services of an advisory nature
or otherwise to, or participate or engage in, any other competing business activity.

 

3.
Term of Employment. This Agreement and the employment relationship and terms hereunder shall continue from the Effective
Date until Employee’s employment is terminated by either the Company or Employee pursuant to Section 6 (the “Employment
Term”).

 

4.
Compensation. During the Employment Period, the Company shall pay the amounts and provide the benefits described in this
Section 4, and Employee agrees to accept such amounts and benefits in full payment for Employee’s services under this Agreement.

 

(a)
Base Salary. The Company shall pay Employee a base salary at the rate of One Hundred Seventy-Two Thousand Four Hundred
dollars ($172,400) per year (the “Base Salary”), in accordance with the customary payroll practices of the
Company applicable to executives. During the Employment Term, the Company’s Compensation Committee of the Board shall review
the Base Salary and may provide for such increases (but not decreases) in Base Salary as it may, in its sole and absolute discretion,
deem appropriate.

 

(b)
Bonus Plans.

 

(i)
Employee shall be eligible to receive a discretionary “Performance Bonus” for each calendar year during the
Term. The Performance Bonus, if any, shall be determined on a calendar year basis in the Company’s sole discretion and shall
be paid as and when determined by the Board, but no later than March 15 of the calendar year following the year to which the Performance
Bonus is attributable.

 

(ii)
Employee shall further be entitled to participate in such bonus programs and plans as the Company makes available from time to
time to Company employees of comparable status, subject to, and to the extent that, Employee is eligible under such bonus programs
and plans in accordance with their respective terms.

 

(c)
Fringe Benefits. Subject to Section 4 (d) below, Employee will be entitled:

 

(i)
to participate, on the same basis as other employees of the Company, in any medical, dental, vision, life, short-term and long-term
disability insurance and flexible spending accounts (subject to certain co-payments by Employee). Employee’s participation
in such plans shall be subject to all terms and conditions of such plans, including Employee’s ability to satisfy any medical
or health requirements imposed by the underwriters of any insurance policies paid to fund the plans; and

 

(ii)
to participate after two full calendar months of employment with the Company, on the same basis as other employees of the Company,
in the Company’s 401(k) plan, with said participation subject to all terms and conditions of such plans.

 

    	2

     

    

 

(d)
Deduction from Compensation. The Company shall deduct and withhold from all compensation payable to Employee all amounts
required to be deducted or withheld pursuant to any present or future law, ordinance, regulation, order, writ, judgment, or decree
requiring such deduction and withholding.

 

(f)
Initial Equity Grant. The Board has approved, and the Company hereby agrees to grant to Employee, effective as of the Effective
Date of this Agreement, options to purchase two hundred thousand (200,000) shares of the Company’s common stock (the “Options”).
A more formal Stock Option Award Agreement reflecting, in all material respects, the terms of this paragraph (and otherwise in
customary form) shall be issued to Employee upon the Company’s shareholders approving a bona fide employee stock option
plan (the “Plan”). Such stockholder approval is anticipated to occur within 30 days of execution of this Agreement.
The Options will vest in thirty six (36) monthly installments in accordance with the following schedule (i) 5,555 shares vesting
each month for 35 consecutive months beginning on the Effective Date and (ii) 5,575 shares vesting on December 8, 2023. The Options
shall vest and become exercisable in full upon the consummation of a “change in control event” (as defined in Section
409A of the Code). All other terms of the Options shall be governed by the Plan and the Stock Option Award Agreement. The Options
are intended to be exempt from Section 409A of the Code, and shall be administered and interpreted consistent with such intent.
Except as otherwise set forth herein in Section 5 or in the Option Award Agreement, vesting of the Options will cease upon the
termination of Employee’s employment with the Company for any reason.

 

(e)
Long Term Equity Incentive. Employee shall be granted three hundred (300,000) restricted stock units (the “RSU’s”)
under and subject to all of the provisions of the related award agreement (the “RSU Award Agreement”), upon and subject
to approval by the Company’s Board of Directors (the “Board”). The RSU’s will be unvested on the grant
date. The Restricted Shares will be issued in such amounts and upon the Company’s Telemedicine Brands achieving certain
revenue milestones (each a “Milestone”) in accordance with Schedule A hereto. RSU’s, if, and to the extent,
issued and when issued, will vest on December 8, 2023. “Telemedicine Brand” shall be defined as any brand owned by
the Company that provides virtual medical treatment or sells any prescription medication. Except as otherwise set forth herein
or in the Milestone Option Agreement, vesting of the Milestone Options will cease upon the termination of Employee’s employment
with the Company subject to the terms of Section 5 below. In addition, all of the RSU’s, if, and to the extent, issued and
when issued, will vest immediately upon a Change of Control. As used herein, “Change of Control” means (i) a bona
fide transfer or series of related transfers of Shares to any person or Group in which, or as a result of which, such person or
Group obtains the direct or indirect right to elect a majority of the board of directors of the Company; or (ii) a sale of all
or substantially all of the assets of the Company. As used herein, “Group” means any group or syndicate that would
be considered a “person” for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended.

 

    	3

     

    

 

5.
TERMINATION

 

5.1
Termination by Company With Good Cause; Employee Resignation. The Company may terminate Employee’s employment at
any time, with notice for Good Cause (as defined below). Similarly, Employee may resign his employment with the Company at any
time, with notice and without Good Reason (as defined below). If the Company terminates Employee’s employment with Good
Cause, or if Employee resigns without Good Reason, then the Company shall pay Employee his base salary prorated through the date
of termination, at the rate in effect at the time notice of termination is given, together with any benefits accrued through the
date of termination (collectively the “Accrued Benefits”). In addition, all options agreements for all options to
purchase the common stock of the Company granted to Employee during his employment with the Company (the “Employee Options”)
shall provide that, notwithstanding any contrary provisions in the Conversion Labs, Inc. 2020 Equity Incentive Plan (the “Plan”),
in the event Employee’s employment is terminated by the Company with Good Cause, the Employee Options to the extent then
vested and exercisable as of the date Employee’s employment is terminated, and not previously terminated in accordance with
such option agreements and the Plan, may be exercised within twelve (12) months after such termination date, or on or prior to
the such option expiration date (as specified and defined in the respective stock option grant notices for the Employee Options),
whichever is earlier. Except with respect to any outstanding equity compensation agreements, the Company shall have no further
obligations to Employee under this Agreement or any other agreement relating to or arising out of Employee’s status as an
employee of the Company (as opposed to some other status with respect to Company, such as a shareholder or holder of a stock option).

 

5.2
Termination Without Good Cause or for Good Reason. The Company shall have the right to terminate Employee’s employment
(with notice) without Good Cause and Employee shall have the right to terminate Employee’s employment (with notice) for
Good Reason (each a “Qualifying Termination”). If there is a Qualifying Termination then the following provisions
in this Section 5.2 shall apply:

 

(a)
The Company shall provide Employee with the Accrued Benefits;

 

(b)
On the six (6) month anniversary of the date Employee’s termination becomes effective, The Company shall pay Employee in
a lump sum an amount equal to (6) months’ base salary (at the rate in effect at the time of termination, but disregarding
any reduction that constitutes Good Reason), plus a pro-rata share of any bonus earned for the year of termination; employee acknowledges
that any and all bonuses are at the discretion of the Board and at the advice of the Compensation Committee.

 

(c)
If Employee timely elects continued coverage under COBRA, the Company will pay Employee’s COBRA premiums necessary to continue
Employee’s coverage (including coverage for eligible dependents, if applicable) (“COBRA Premiums”) through the
period (the “COBRA Premium Period”) starting on the date of termination and ending on the earliest to occur of: (i)
six months following the date of termination or (ii) the date Employee and Employee’s eligible dependents, if applicable,
become eligible for group health insurance coverage through a new employer. In the event Employee becomes covered under another
employer’s group health plan during the COBRA Premium Period, Employee must immediately notify Company of such event.

 

To
be eligible for the severance payment provided for in this Section 5.2, Employee must have executed and not revoked a full and
complete general release of any and all claims against the Company and related persons and entities in the standard form then
used by the Company (“Release”), within 60 days of the date of termination. Upon making all of the applicable severance
payments and benefits, except with respect to any outstanding equity compensation agreements, the Company shall have no further
obligations to Employee under this Agreement or any other agreement relating to or arising out of Employee’s status as an
employee of the Company (as opposed to some other status with respect to the Company, such as a shareholder or holder of a stock
option).

 

    	4

     

    

 

5.3
Good Cause. For purposes of this Agreement, a termination shall be for “Good Cause” if Employee, shall:

 

(a)
Commit an act of fraud, moral turpitude, misappropriation of funds or embezzlement in connection with his duties;

 

(b)
Breach Employee’s fiduciary duty to the Company, including, but not limited to, acts of self-dealing (whether or not for
personal profit);

 

(c)
Materially breach this Agreement, the Confidentiality Agreement (defined below), or Company’s written Codes of Ethics as
adopted by the Board;

 

(d)
Willfully, recklessly, or negligently violate any material provision of Company’s written Employee Handbook, if applicable,
or any applicable state or federal law or regulation;

 

(e)
Fail or refuse (whether willfully, recklessly or negligently) to materially comply with all relevant and material obligations,
assumable and personally chargeable to an executive of his corporate rank and responsibilities, under the Sarbanes-Oxley Act and
the regulations of the Securities and Exchange Commission promulgated thereunder (for avoidance of doubt any failure by the Company
to comply with foregoing laws and regulations shall not be imputed on to Employee for purposes of this provision);

 

(f)
Fail to or refuse to (whether willfully, recklessly or negligently) to perform the responsibilities and duties specified herein
(other than a failure caused by temporary disability and provided further that the mere failure to achieve certain goals or objectives
(provided Employee has attempted in good faith to achieve such goals and objectives) shall not constitute Good Cause);

 

(g)
Be convicted of, or enter a plea of guilty or no contest to, a felony or misdemeanor under state or federal law in a court of
competent jurisdiction, other than a traffic violation or misdemeanor not involving dishonesty or moral turpitude;

 

(h)
Fail to return any compensation amount required to be clawed back or returned to the Company by application of any applicable
law or regulation.

 

    	5

     

    

 

The
foregoing is an exhaustive list of the items that constitute Cause under this Agreement. Notwithstanding the foregoing, other
than with respect to clause (g), “Good Cause” shall only be found to exist if, prior to Employee’s termination
and within ninety (90) days after the Company’s initial awareness of an event of Good Cause, the Company has provided (i)
written notice to the Employee describing such Good Cause event(s), (ii) the Employee does not cure such event within ten (10)
days following the Employee’s receipt of such notice from the Company, (iii) an opportunity for the Employee, together with
counsel, to be heard before the Board or subcommittee of the Board of Directors of the Company, .

 

5.4
Death or Disability. To the extent consistent with federal and state law, upon written notice to Employee, the Company
may terminate Employee’s employment due to Employee’s Disability. Additionally, Employee’s employment shall
terminate on Employee’s death. “Disability” means (i) Employee’s inability to engage in any substantial,
gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death
or can be expected to last for a continuous period of not less than twelve (12) months, or (ii) Employee is, by reason of any
medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a
continuous period of not less than twelve (12) months, receiving income replacement benefits for a period of not less than three
(3) months under an accident or health plan covering the Company’s employees. In the event of termination due to death or
Disability, Company shall pay Employee (or his legal representative) his base salary prorated through the date of termination,
at the rate in effect at the time of termination, together with any benefits accrued, including, but not limited to, a pro-rata
share of any bonus earned for the year of termination, through the date of termination. Any such bonus shall be payable in the
calendar year following the performance year. In addition, all option agreements for the shall provide that, notwithstanding any
contrary provisions in the Plan, in the event Employee’s employment is terminated due to Employee’s death or Disability,
any vested portion of the options not previously terminated in accordance with such option agreements and the Plan, may be exercised
within five (5) years after the termination date, or on or prior to the option expiration date (as specified and defined in the
respective stock option grant notices for such options), whichever is earlier.

 

5.5
Return of Company Property. Within fourteen (14) days after the Employees termination of employment, Employee shall return
to the Company all products, books, records, forms, specifications, formulae, data processes, designs, papers and writings relating
to the business of the Company including without limitation proprietary or licensed computer programs, customer lists and customer
data, and/or copies or duplicates thereof in Employee’s possession or under Employee’s control. Employee shall not
retain any copies or duplicates of such property and all licenses granted to him by the Company to use computer programs or software
shall be revoked on the termination date.

 

5.6
Good Reason. For purposes of this Agreement, a termination shall be for “Good Reason” if the Company:

 

(a)
Materially reduced the duties and responsibilities assigned to Employee under this Agreement;

 

    	6

     

    

 

 

(b)
Reduced Employee’s base salary by 50% or more; or

 

(c)
Materially breached this Agreement or any other written agreement with Employee.

 

Notwithstanding
the foregoing, “Good Reason” shall only be found to exist if, prior to Employee’s resignation and within ninety
(90) days after the initial existence of an event of Good Reason, Employee has provided written notice to the Company describing
such alleged Good Reason event(s), and the Company does not cure such event within thirty (30) days following the Company’s
receipt of such notice from Employee, and the date of Employee’s termination of employment due to Employee’s resignation
for Good Reason occurs within ninety (90) days after the expiration of the foregoing thirty (30) day cure period.

 

6.
Covenants of Employee.

 

(a)
Employee will truthfully and accurately make, maintain, and preserve all records and reports that the Company may from time to
time reasonably request or require;

 

(b)
Employee will obey all rules, regulations and reasonable special instructions applicable to Employee, and will be loyal and faithful
to the Company at all times, constantly endeavoring to improve Employee’s ability and knowledge of the business in an effort
to increase the value of Employee’s services to the mutual benefit of the Parties;

 

(c)
Employee will make available to the Company any and all of the information of which Employee has knowledge relating to the business
of the Company or any of the Company’s other Subsidiaries and will make all suggestions and recommendations which Employee
feels will be of benefit to the Company;

 

(d)
Employee will fully account for all money, records, goods, wares and merchandise or other property belonging to the Company of
which Employee has custody, and will pay over and deliver the same promptly whenever and however he may be reasonably directed
to do so;

 

(e)
Employee acknowledges that as a condition of employment, he must sign and comply with the Employee Confidential Information and
Inventions Assignment Agreement attached hereto as Exhibit A, which prohibits unauthorized use or disclosure of the Company’s
proprietary information, among other obligations;

 

(f)
Employee agrees that upon termination of his employment hereunder he will immediately surrender and turn over to the Company all
books, records, forms, specifications, formulae, data, processes, papers and writings related to the business of the Company,
and all other property belonging to the Company, together with all copies of the foregoing, it being understood and agreed that
the same are the sole property, directly or indirectly, of the Company;

 

(g)
Employee understands that in his performing work for the Company, he will be expected not to use or disclose any confidential
information, including trade secrets, of any former employer or other person to Employee has an obligation of confidentiality.
Rather, Employee further understands that he will be expected to use only that information which is generally known and used by
persons with training and experience comparable to his own, which is common knowledge in the industry or otherwise legally in
the public domain, or which is otherwise provided or developed by the Company. Employee agrees that he will not bring onto Company
premises any unpublished documents or property belonging to any former employer or other person to whom Employee has an obligation
of confidentiality. Employee hereby represents that he has disclosed to the Company any contract he has signed that may restrict
Employee’s activities on behalf of the Company.

 

    	7

     

    

 

(h)
Employee acknowledges and understands that the securities of the Company are publicly traded and subject to the Securities Act
of 1933 and the Securities Exchange Act of 1934. As a result, Employee acknowledges and agrees that (i) he is required under applicable
securities laws to refrain from trading in securities of the Company while in possession of material nonpublic information and
to refrain from disclosing any material nonpublic information to anyone except as permitted by this Agreement in connection with
the performance of Employee’s duties hereunder, and (ii) he will communicate to any person to whom Employee communicates
any material nonpublic information that such information is material nonpublic information and that the trading and disclosure
restrictions in clause (i) above also apply to such person.

 

7.
NO SOLICITATION

 

(a)
No Solicitation of Employees. Employee agrees that he will not, during his employment with the Company, and for two (2)
years thereafter, encourage or solicit any other employee of the Company to terminate his or her employment for any reason, nor
will he assist others to do so (provided however that former Company employees and/or Company employees responding to general
ads or solicitations shall not be covered by this Section 7(a).

 

(b)
No Solicitation of Customer. Employee agrees that he will not, during his employment with the Company, and for two (2)
years thereafter, directly or indirectly, utilize any Company information protected under the Employee Confidential Information
and Inventions Assignment Agreement to solicit any client or customer of the Company known to him with respect to any business,
products or services that are competitive to the products or services offered by the Company, or under development as of the date
of the termination of Employee’s employment with the Company for any reason.

 

8.
Amendment and Waiver. This Agreement may not be changed orally but only by written documents signed by the Party against
whom enforcement of any waiver, change, modification, extension or discharge is sought; however, the amount of compensation to
be paid to Employee for services to be performed for the Company hereunder may be changed from time to time by the Parties by
written agreement without in any other way modifying, changing or affecting this Agreement or the performance by Employee of any
of the duties of his employment with the Company. Any such written agreement shall be, and shall be conclusively deemed to be,
a ratification and confirmation of this Agreement, except as expressly set forth in such written amendment. The waiver by any
Party of a breach of any provision of this Agreement shall not operate as or be construed to be a waiver of any subsequent breach
thereof, nor of any breach of any other term or provision of this Agreement.

 

    	8

     

    

 

9.
Notice. All notices and other communications hereunder shall be in writing and shall be deemed duly delivered (a) three
business days after being received by registered or certified mail, return receipt requested, postage prepaid, or (b) three business
days after being sent for next business day delivery, fees prepaid, via a reputable nationwide overnight courier service, in the
case of the Company, to its principal office address, and in the case of Employee, to Employee’s residence address as shown
on the records of the Company, or may be given by personal delivery thereof.

 

10.
Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be valid and
enforceable under applicable law, but if any provision of this Agreement shall be invalid, unenforceable or prohibited by applicable
law, then in lieu of declaring such provision invalid or unenforceable, to the extent permitted by law (a) the Parties agree that
they will amend such provision to the minimal extent necessary to bring such provision within the ambit of enforceability, and
(b) any court of competent jurisdiction may, at the request of either party, revise, reconstruct or reform such provision in a
manner sufficient to cause it to be valid and enforceable.

 

11.
Entire Agreement. This Agreement, together with the Employee Confidential Information and Inventions Assignment Agreement,
forms the complete and exclusive statement of Employee’s employment agreement with the Company. It supersedes any other
agreements, representations or promises made to Employee by anyone, whether oral or written. Changes in Employee’s employment
terms, other than those changes expressly reserved to the Company’s discretion in this Agreement, require a written modification
signed by an officer of the Company.

 

12.
Force Majeure. Neither of the Parties shall be liable to the other for any delay or failure to perform hereunder, which
delay or failure is due to causes beyond the control of said Party, including, but not limited to: acts of God; acts of the public
enemy; acts of the United States of America or any state, territory or political subdivision thereof or of the District of Columbia;
fires; floods; epidemics, quarantine restrictions; strike or freight embargoes. Notwithstanding the foregoing provisions of this
Section 12 in every case the delay or failure to perform must be beyond the control and without the fault or negligence of the
Party claiming excusable delay.

 

    	9

     

    

 

13.
Arbitration. To ensure the rapid and economical resolution of disputes that may arise in connection with your employment
with the Company, Employee and the Company agree that any and all disputes, claims, or causes of action, in law or equity, including
but not limited to statutory claims, arising from or relating to the enforcement, breach, performance, or interpretation of this
Agreement, Employee’s employment with the Company, or the termination of Employee’s employment, shall be resolved
pursuant to the Federal Arbitration Act, 9 U.S.C. § 1-16, to the fullest extent permitted by law, by final, binding and confidential
arbitration conducted by JAMS or its successor, under JAMS’ then applicable rules and procedures for employment disputes
(available upon request and also currently available at http://www.jamsadr.com/rules-employment-arbitration/). Employee
acknowledges that by agreeing to this arbitration procedure, both Employee and the Company waive the right to resolve any such
dispute through a trial by jury or judge or administrative proceeding. In addition, all claims, disputes, or causes of action
under this section, whether by Employee or the Company, must be brought in an individual capacity, and shall not be brought as
a plaintiff (or claimant) or class member in any purported class or representative proceeding, nor joined or consolidated with
the claims of any other person or entity. The arbitrator may not consolidate the claims of more than one person or entity and
may not preside over any form of representative or class proceeding. To the extent that the preceding sentences regarding class
claims or proceedings are found to violate applicable law or are otherwise found unenforceable, any claim(s) alleged or brought
on behalf of a class shall proceed in a court of law rather than by arbitration. This paragraph shall not apply to any action
or claim that cannot be subject to mandatory arbitration as a matter of law, including, without limitation, claims brought pursuant
to the California Private Attorneys General Act of 2004, as amended, the California Fair Employment and Housing Act, as amended,
and the California Labor Code, as amended, to the extent such claims are not permitted by applicable law(s) to be submitted to
mandatory arbitration and the applicable law(s) are not preempted by the Federal Arbitration Act or otherwise invalid (collectively,
the “Excluded Claims”). In the event Employee intends to bring multiple claims, including one of the Excluded
Claims listed above, the Excluded Claims may be filed with a court, while any other claims will remain subject to mandatory arbitration.
Employee will have the right to be represented by legal counsel at any arbitration proceeding. The arbitrator shall: (a) have
the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted
by law; and (b) issue a written statement signed by the arbitrator regarding the disposition of each claim and the relief, if
any, awarded as to each claim, the reasons for the award, and the arbitrator’s essential findings and conclusions on which
the award is based. The arbitrator shall be authorized to award all relief that Employee or the Company would be entitled to seek
in a court of law. The Company shall pay all JAMS arbitration fees in excess of the administrative fees that Employee would be
required to pay if the dispute were decided in a court of law. Nothing in this Agreement is intended to prevent either Employee
or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration.

 

14.
Recovery of Litigation Costs. If any legal action or other proceeding is brought for the enforcement of this Agreement
or any agreement or instrument delivered under or in connection with this Agreement, or because of an alleged dispute, breach,
default or misrepresentation in connection with any of the provisions of this Agreement, the successful or prevailing Party or
Parties shall be entitled to recover reasonable attorneys’ fees and other costs incurred in that action or proceeding, in
addition to any other relief to which it or they may be entitled.

 

15.
Successors.

 

(a)
No rights or obligations of Employee under this Agreement may be assigned or transferred by Employee other than Employee’s
rights to payments or benefits hereunder, which may be transferred only by will or the laws of descent and distribution. Upon
Employee’s death, this Agreement and all rights of Employee hereunder shall inure to the benefit of and be enforceable by
Employee’s beneficiary or beneficiaries, personal or legal representatives, or estate, to the extent any such person succeeds
to Employee’s interests under this Agreement. Subject to compliance with the terms of any Company sponsored benefit plan,
Employee shall be entitled to select and change a beneficiary or beneficiaries to receive following Employee’s death any
benefit or compensation payable hereunder by giving the Company written notice thereof. In the event of Employee’s death
or a judicial determination of Employee’s incompetence, reference in this Agreement to Employee shall be deemed, where appropriate,
to refer to Employee’s beneficiary(ies), estate or other legal representative(s).

 

    	10

     

    

 

(b)
This Agreement shall inure to the benefit of and be binding upon the Company and its successors and permitted assigns.

 

(c)
The Company shall have the right to assign this Agreement to any successor of substantially all of its business or assets, and
any such successor shall be bound by all of the provisions hereof.

 

16.
Governing Law. This Agreement and the rights and obligations of the Parties shall be governed by and construed and enforced
in accordance with the substantive laws of California.

 

17.
Counsel. The parties acknowledge and represent that, prior to the execution of this Agreement, they have had an opportunity
to consult with their respective counsel concerning the terms and conditions set forth herein. Additionally, Employee represents
that he has had an opportunity to receive independent legal advice concerning the taxability of any consideration received under
this Agreement. Employee has not relied upon any advice from the Company and/or its attorneys with respect to the taxability of
any consideration received under this Agreement. Employee further acknowledges that the Company has not made any representations
to him with respect to tax issues.

 

18.
No Punitive Damages. If any dispute arises regarding the application, interpretation, or enforcement of any provision of
this Agreement, including fraud in the inducement, the parties hereby waive their right to seek punitive damages in connection
with said dispute.

 

19.
Multiple Counterparts. This Agreement may be executed in multiple counterparts each of which shall be deemed to be an original
but all of which together shall constitute but one instrument.

 

[Signatures
on Next Page]

 

    	11

     

    

 

EXECUTED
as of the day and year first above set forth.

 

	CONVERSION
    LABS, INC.	 
	 	 	 
	 	 
	By:	Justin
    Schreiber, Chairman & CEO 	 
	 	 	 
	eMPLOYEE	 
	 	 	 
	 	 
	By:
    	Nicholas
    Alvarez	 

 

    	12

     

    

 

SCHEDULE
A

 

RESTRICTED
SHARE GRANT

 

Up
to 300,000 RSU’s vesting on December 8, 2023 upon achieving milestones in connection with the Company’s Net Sales
of its Telemedicine Brands. Net sales means the sum of a company’s gross sales minus its returns and chargebacks. 

 

	Number
    of Shares Vested	 	Revenue
    Milestones
	150,000	 	$100,000,000
    in Net Sales in any calendar year
	150,000	 	$200,000,000
    in Net Sales in any calendar year

 

    	13Exhibit
4.1

 

EXECUTION
VERSION

 

NEITHER
THIS DEBENTURE NOR THE SECURITIES INTO WHICH THIS DEBENTURE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR
SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM,
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.

 

KRAIG
BIOCRAFT LABORATORIES, INC.

 

Secured
Convertible Debenture

 

	Issuance
    Date: December 11, 2020	Original
    Principal Amount:	$1,000,000
	No.
    KBLB-1-1	Original
    Issue Discount:	5%

 

FOR
VALUE RECEIVED, KRAIG BIOCRAFT LABORATORIES, INC., a Wyoming corporation (the “Company”), hereby promises
to pay to the order of YAII PN, LTD. or registered assigns (the “Holder”) the amount set out above as the Original
Principal Amount (as reduced pursuant to the terms hereof pursuant to redemption, conversion or otherwise, the “Principal”)
when due, whether upon the Maturity Date (as defined below), on any Installment Date with respect to the Installment Amount due
on such Installment Date (each, as defined herein), acceleration, redemption or otherwise (in each case in accordance with the
terms hereof) and to pay interest (“Interest”) on any outstanding Principal at the applicable Interest Rate
from the date set out above as the Issuance Date (the “Issuance Date”) until the same becomes due and payable,
whether upon any Installment Date or the Maturity Date or acceleration, conversion, redemption or otherwise (in each case in accordance
with the terms hereof). This Secured Convertible Debenture (including all Secured Convertible Debentures issued in exchange, transfer
or replacement hereof, this “Debenture”) is issued pursuant to the Securities Purchase Agreement. Certain capitalized
terms used herein are defined in Section 17.

 

(1)
GENERAL TERMS

 

(a)
Payment of Principal. Commencing on July 1, 2021 and on each Installment Date thereafter, the Company shall pay to the
Holder an amount equal to the Installment Amount due on such Installment Date in accordance with Section 3 and as set forth on
Exhibit II hereto. On the Maturity Date, the Company shall pay to the Holder an amount in cash representing all outstanding
Principal, accrued and unpaid Interest. The “Maturity Date” shall be January 11, 2022, as may be extended at
the option of the Holder (i) in the event that, and for so long as, an Event of Default (as defined below) shall have occurred
and be continuing on the Maturity Date (as may be extended pursuant to this Section 1) or any event shall have occurred and be
continuing on the Maturity Date (as may be extended pursuant to this Section 1) that with the passage of time and the failure
to cure would result in an Event of Default. Other than as specifically permitted by this Debenture, the Company may not prepay
or redeem any portion of the outstanding Principal without the prior written consent of the Holder.

 

    	 

    	 

    

 

(b)
Interest. Interest shall accrue on the outstanding principal balance hereof at an annual rate equal to 10% (“Interest
Rate”). Interest shall be calculated on the basis of a 365-day year and the actual number of days elapsed, to the extent
permitted by applicable law. Interest hereunder shall be paid on each Installment Date and on the Maturity Date (or sooner as
provided herein) to the Holder or its assignee in whose name this Debenture is registered on the records of the Company regarding
registration and transfers of Debentures at the option of the Company in cash, or, provided that the Equity Conditions are then
satisfied converted into Common Stock at the Market Conversion Price on the Trading Day immediately prior to the date paid.

 

(c)
Original Issue Discount. The Original Principal Amount of this Debenture shall have an original issue discount of 5% (the
“OID”) which the Holder shall be entitled to deduct from the gross proceeds of the Original Principal Amount
when this Debenture was issued.

 

(2)
EVENTS OF DEFAULT.

 

(a)
An “Event of Default”, wherever used herein, means any one of the following events (whatever the reason and
whether it shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any
court, or any order, rule or regulation of any administrative or governmental body:

 

(i)
the Company’s failure to pay to the Holder any amount of Principal, Interest, or other amounts when and as due under this
Debenture (including, without limitation, the Company’s failure to pay any redemption payments or amounts hereunder) or
any other Transaction Document;

 

(ii)
The Company or any subsidiary of the Company shall commence, or there shall be commenced against the Company or any subsidiary
of the Company under any applicable bankruptcy or insolvency laws as now or hereafter in effect or any successor thereto, or the
Company or any subsidiary of the Company commences any other proceeding under any reorganization, arrangement, adjustment of debt,
relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction whether now or hereafter in effect
relating to the Company or any subsidiary of the Company or there is commenced against the Company or any subsidiary of the Company
any such bankruptcy, insolvency or other proceeding which remains undismissed for a period of 61 days; or the Company or any subsidiary
of the Company is adjudicated insolvent or bankrupt; or any order of relief or other order approving any such case or proceeding
is entered; or the Company or any subsidiary of the Company suffers any appointment of any custodian, private or court appointed
receiver or the like for it or any substantial part of its property which continues undischarged or unstayed for a period of 61
days; or the Company or any subsidiary of the Company makes a general assignment for the benefit of creditors; or the Company
or any subsidiary of the Company shall fail to pay, or shall state that it is unable to pay, or shall be unable to pay, its debts
generally as they become due; or the Company or any subsidiary of the Company shall call a meeting of its creditors with a view
to arranging a composition, adjustment or restructuring of its debts; or the Company or any subsidiary of the Company shall by
any act or failure to act expressly indicate its consent to, approval of or acquiescence in any of the foregoing; or any corporate
or other action is taken by the Company or any subsidiary of the Company for the purpose of effecting any of the foregoing;

 

    	2

    	 

    

 

(iii)
The Company or any subsidiary of the Company shall default in any of its obligations under any other debenture or any mortgage,
credit agreement or other facility, indenture agreement, factoring agreement or other instrument under which there may be issued,
or by which there may be secured or evidenced any indebtedness for borrowed money or money due under any long term leasing or
factoring arrangement of the Company or any subsidiary of the Company in an amount exceeding $100,000, whether such indebtedness
now exists or shall hereafter be created and such default shall result in such indebtedness becoming or being declared due and
payable prior to the date on which it would otherwise become due and payable;

 

(iv)
If the Common Stock ceases to be so quoted or listed for trading and shall not again be quoted or listed for trading on the OTCQB-MKT
(the “Primary Market”) within 5 Trading Days of such delisting, unless such cessation is the result of the
Common Stock being listed on the Nasdaq Capital Markets or a similar exchange;

 

(v)
The Company or any subsidiary of the Company shall be a party to any Change of Control Transaction (as defined in Section 6) unless
in connection with such Change of Control Transaction this Debenture is retired;

 

(vi)
the Company’s (A) failure to cure a Conversion Failure by delivery of the required number of shares of Common Stock within
3 Business Days after the applicable Conversion Failure or (B) notice, written or oral, to any holder of the Debenture, including
by way of public announcement, at any time, of its intention not to comply with a request for conversion of the Debenture into
shares of Common Stock that is tendered in accordance with the provisions of the Debentures, other than pursuant to Section 4(e);

 

(vii)
The Company shall fail for any reason to deliver the payment in cash pursuant to a Buy-In (as defined herein) within 3 Business
Days after such payment is due;

 

(viii)
The Company shall fail to observe or perform any other covenant, agreement or warranty contained in, or otherwise commit any breach
or default of any provision of this Debenture (except as may be covered by Section 2(a)(i) through 2(a)(vii) hereof) or any Transaction
Documents (as defined in Section 17) which is not cured within the time prescribed.

 

    	3

    	 

    

 

(ix)
any Event of Default occurs with respect to any Transaction Document, which is not cured within any applicable cure period set
forth therein.

 

(b)
During the time that any portion of this Debenture is outstanding, if any Event of Default has occurred, the full unpaid Principal
amount of this Debenture, together with interest and other amounts owing in respect thereof, to the date of acceleration shall
become at the Holder’s election, immediately due and payable in cash; provided however, the Holder may request (but shall
have no obligation to request) payment of such amounts in Common Stock of the Company. If an Event of Default occurs and for so
long as such Event of Default remains uncured, the Interest Rate on this Debenture shall immediately become 15% per annum and
shall remain at such increased interest rate until the applicable Event of Default is cured. Furthermore, in addition to any other
remedies, the Holder shall have the right (but not the obligation) to convert this Debenture at any time after (x) an Event of
Default at the Market Conversion Price. The Holder need not provide and the Company hereby waives any presentment, demand, protest
or other notice of any kind, (other than required notice of conversion) and the Holder may immediately and without expiration
of any grace period enforce any and all of its rights and remedies hereunder and all other remedies available to it under applicable
law. Such declaration may be rescinded and annulled by Holder at any time prior to payment hereunder. No such rescission or annulment
shall affect any subsequent Event of Default or impair any right consequent thereon.

 

(3)
COMPANY INSTALLMENT IN CASH, CONVERSION OR REDEMPTION.

 

(a)
General. On each applicable Installment Date, the Company shall pay to the Holder of this Debenture the Installment Amount
in cash plus the applicable Cash Payment Premium (a “Company Installment Cash Payment”) or by converting such
Installment Amount into shares of Common Stock of the Company, provided that there is not then an Equity Conditions Failure, in
accordance with this Section 3 (a “Company Installment Conversion Payment”) or by any combination of a Company
Installment Cash Payment and a Company Installment Conversion Payment so long as all of the outstanding applicable Installment
Amount shall be paid (whether in cash or converted into shares of the Company’s Common Stock as provided for herein) on
the applicable Installment Date, subject to the provisions of this Section 3.

 

(b)
On or prior to the date which is the 5th Trading Day prior to each Installment Date (each, an “Installment
Notice Due Date”), the Company shall deliver written notice (each, a “Company Installment Notice”),
to the Holder which Company Installment Notice shall either (A) confirm that the applicable Installment Amount of the Holder’s
Debenture shall be converted, in whole pursuant to a Company Installment Conversion Payment, (B) confirm that the applicable Installment
Amount of the Holder’s Debenture shall be paid in cash in whole pursuant to a Company Installment Cash Payment or (C) state
that the Company elects to pay the Installment Amount part in cash, pursuant to a Company Installment Cash Payment and specify
the portion (including Interest and the applicable Cash Payment Premium) which the Company elects or is required to pay in cash
(the “Company Installment Cash Amount”) and (2) the portion (including Interest) of the Installment Amount,
that the Company elects to convert pursuant to a Company Installment Conversion Payment (such amount a “Company Installment
Conversion Amount”) which amounts when added together, must equal the applicable Installment Amount and certify that
there is not then an Equity Conditions Failure as of the date of the Company Installment Notice. The Company shall wire such Company
Installment Cash Amount to the Holder in accordance with the wiring instructions attached here to as Exhibit III.

 

    	4

    	 

    

 

Each
Company Installment Notice shall be irrevocable. If the Company does not timely deliver a Company Installment Notice in accordance
with this Section 3, then the Company shall be deemed to have delivered an irrevocable Company Installment Notice confirming a
Company Installment Conversion Payment and shall be deemed to have certified that there is not then an Equity Conditions Failure
in connection with any such conversion. The Company Installment Conversion Amount (whether set forth in the Company Installment
Notice or by operation of this Section 3) shall be converted in accordance with Section 3(c). Any Company Installment Cash Amount
shall be paid in accordance with Section 3(d).

 

(c)
Mechanics of Company Installment Conversion Payment. Subject to Section 4(e)(i), if the Company delivers a Company Installment
Notice and elects, or is deemed to have elected, in whole or in part, a Company Installment Conversion Payment in accordance with
Section 3(b), then the applicable Company Installment Conversion Amount, shall be converted as of the applicable Installment Date
by converting on such Installment Date such Company Installment Conversion Amount at the Market Conversion Price; provided that
the Equity Conditions are then satisfied (or waived in writing by the Holder). Such shares of the Company’s Common Stock
to be delivered in connection with such Company Installment Conversion Payment shall be made in accordance with Section 4(e)(i)
herein.

 

If
the Equity Conditions are not satisfied (or waived in writing by the Holder), then at the option of the Holder designated in writing
to the Company, the Holder may require the Company to do any one or more of the following: (i) the Company shall redeem pursuant
to the terms of the Debenture all or any part of the unconverted Company Installment Conversion Amount designated by the Holder
(such designated amount is referred to as the “Unconverted Installment Amount”) and the Company shall pay to
the Holder within 3 days of such Installment Date, by wire transfer of immediately available funds, an amount in cash equal to
such Unconverted Installment Amount, and/or (ii) the Company Installment Conversion Payment shall be null and void with respect
to all or any part of the unconverted Company Installment Conversion Amount designated by the Holder and the Holder shall be entitled
to all the rights of a holder of this Debenture with respect to such designated amount of the Company Installment Conversion Amount;
provided, however, that the Market Conversion Price for such unconverted Company Installment Conversion Amount shall thereafter
be adjusted to equal the lesser of (A) the Market Conversion Price as in effect on the date on which the Holder voided the Company
Installment Conversion Payment and (B) the Market Conversion Price as in effect on the date on which the Holder delivers a Conversion
Notice relating thereto. If the Company fails to redeem any Unconverted Installment Amount by the 3rd day following
the applicable Installment Date, then the Holder shall have all rights under this Debenture (including, without limitation, such
failure constituting an Event of Default) and notwithstanding anything to the contrary in this Section 3(c), but subject to Section
4(e)(i), until the Company delivers Common Stock representing the Company Installment Conversion Amount to the Holder, the Company
Installment Conversion Amount may be converted by the Holder into Common Stock pursuant to Section 4. In the event that the Holder
elects to convert the Company Installment Conversion Amount prior to the applicable Installment Date as set forth in the immediately
preceding sentence, the Company Installment Conversion Amount so converted shall be deducted from the Installment Amount relating
to the applicable Installment Date as set forth in the applicable Conversion Notice.

 

    	5

    	 

    

 

(d)
Mechanics of Company Installment Cash Payment. If the Company elects a Company Installment Cash Payment in accordance with
Section 3(b), then the Company Installment Cash Amount, if any, which is to be paid to the Holder on the applicable Installment
Date shall be paid by the Company on such Installment Date, to the Holder by wire transfer of immediately available funds, in
an amount in cash equal to the Company Installment Cash Amount plus the Cash Payment Premium of the Principal portion of the Company
Redemption Amount plus accrued and unpaid Interest. If the Company fails to deliver to the Holder via wire transfer the Company
Installment Cash Amount on the applicable Installment Date then at the option of the Holder designated in writing to the Company
(any such designation, “Conversion Notice” for purposes of this Debenture), the Holder may require the Company
to convert all or any part of the Company Installment Cash Amount into shares of Common Stock of the Company at the Market Conversion
Price. Conversions required by this Section 3(d) shall be made in accordance with the provisions of Section 4(d). Notwithstanding
anything to the contrary in this Section 3(d), but subject to Section 4(e)(i), until the Company Installment Cash (together with
Interest and the applicable Cash Payment Premium) is paid in full, the Company Installment Cash Amount (together with any interest
thereon and the applicable Cash Payment Premium) may be converted, in whole or in part, by the Holder into Common Stock pursuant
to Section 4. In the event the Holder elects to convert all or any portion of the Company Installment Cash Amount prior to the
applicable Installment Date as set forth in the immediately preceding sentence, the Company Installment Cash Amount so converted
shall be deducted from the Installment Amount relating to the applicable Installment Date as set forth in the applicable Conversion
Notice.

 

(e)
Company’s Cash Redemption. The Company at its option shall have the right to redeem (a “Redemption”),
in part or in whole, outstanding Principal and Interest under this Debenture in addition to any Installment Amount payments prior
to the Maturity Date. The Company shall pay an amount equal to the principal amount being redeemed plus a redemption premium (“Redemption
Premium”) equal to 1) if such Redemption occurs within 180 calendar days from the date hereof an amount equal to 10%
of the outstanding Principal Amount being redeemed plus outstanding and accrued Interest and 2) if such Optional Redemption occurs
after 180 calendar days from the date hereof an amount equal to 15% of the outstanding Principal Amount plus outstanding and accrued
Interest. In order to make a Redemption pursuant to this Section, the Company shall first provide 7 business days advanced written
notice to the Holder of its intention to make a redemption (the “Redemption Notice”) setting forth the amount
of Principal and Interest it desires to redeem plus the applicable Redemption Premium (the “Redemption Amount”).
After receipt of the Redemption Notice the Holder shall have 7 Business Days to elect to convert all or any portion of this Debenture,
subject to the limitations set forth in Section 3(e). On the 8th Business Day after the Redemption Notice, the Company
shall deliver to the Holder via wire transfer of immediately available funds the Redemption Amount with respect to the Principal
Amount and Interest redeemed after giving effect to conversions by the Holder effected during the 7 Business Day period.

 

    	6

    	 

    

 

(4)
CONVERSION OF DEBENTURE. This Debenture shall be convertible into shares of the Company’s Common Stock, on the terms
and conditions set forth in this Section 4.

 

(a)
Conversion Right. Subject to the provisions of Section 4(e), at any time or times on or after an Event of Default or as
provided for in Section 3(e), the Holder shall be entitled to convert any portion of the outstanding and unpaid Conversion Amount
(as defined below) into fully paid and nonassessable shares of Common Stock in accordance with Section 4(e)(i), at the Market
Conversion Price. The number of shares of Common Stock issuable upon conversion of any Conversion Amount pursuant to this Section
4(a) shall be determined by dividing (x) such Conversion Amount by (y) the Market Conversion Price (the “Conversion Rate”).
The Company shall not issue any fraction of a share of Common Stock upon any conversion. If the issuance would result in the issuance
of a fraction of a share of Common Stock, the Company shall round such fraction of a share of Common Stock up to the nearest whole
share. The Company shall pay any and all transfer, stamp and similar taxes that may be payable with respect to the issuance and
delivery of Common Stock upon conversion of any Conversion Amount.

 

(b)
“Conversion Amount” means the portion of the Principal and accrued Interest to be converted, redeemed or otherwise
with respect to which this determination is being made.

 

(c)
“Market Conversion Price” means, as of any Conversion Date (as defined below) or other date of determination,
90% of the lowest VWAP of the Company’s Common Stock during the 10 Trading Days immediately preceding the Conversion Date.
All such determinations to be appropriately adjusted for any stock split, stock dividend, stock combination or other similar transaction.
In that event that the Company’s Common Stock is uplisted to the Nasdaq as the Primary Market the Market Conversion Price
shall not be less than 20% of the Market Conversion Price for the first conversion hereunder (the “Nasdaq Floor Price”).

 

(d)
Mechanics of Conversion.

 

(i)
Optional Conversion. To convert any Conversion Amount into shares of Common Stock on any date (a “Conversion Date”),
the Holder shall (A) transmit by electronic mail (or otherwise deliver), for receipt on or prior to 5:00 p.m., New York Time,
on such date, a copy of an executed notice of conversion in the form attached hereto as Exhibit I (the “Conversion
Notice”) to the Company and (B) if required by Section 4(d)(iv), surrender this Debenture to a nationally recognized
overnight delivery service for delivery to the Company (or an indemnification undertaking reasonably satisfactory to the Company
with respect to this Debenture in the case of its loss, theft or destruction). On or before the 3rd Business Day following (i)
the date of receipt of a Conversion Notice or (ii) an Installment Date if the Company has delivered a Company Installment Notice
pursuant to which a Company Installment Conversion Payment will be made (the “Share Delivery Date”), the Company
shall (X) if legends are not required to be placed on certificates of Common Stock pursuant to the Securities Purchase Agreement
and provided that the Transfer Agent is participating in the Depository Trust Company’s (“DTC”) Fast
Automated Securities Transfer Program, credit such aggregate number of shares of Common Stock to which the Holder shall be entitled
to the Holder’s or its designee’s balance account with DTC through its Deposit Withdrawal Agent Commission system
or (Y) if the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program, issue and deliver to
the address as specified in the Conversion Notice, a certificate, registered in the name of the Holder or its designee, for the
number of shares of Common Stock to which the Holder shall be entitled which certificates shall not bear any restrictive legends
unless required pursuant to Section 2(g) of the Securities Purchase Agreement. If this Debenture is physically surrendered for
conversion and the outstanding Principal of this Debenture is greater than the Principal portion of the Conversion Amount being
converted, then the Company shall as soon as practicable and in no event later than 3 Business Days after receipt of this Debenture
and at its own expense, issue and deliver to the holder a new Debenture representing the outstanding Principal not converted.
The Person or Persons entitled to receive the shares of Common Stock issuable upon a conversion of this Debenture shall be treated
for all purposes as the record holder or holders of such shares of Common Stock upon the transmission of a Conversion Notice pursuant
to this Section 4(e)(i).

 

    	7

    	 

    

 

(ii)
Company’s Failure to Timely Convert. If within 3 Trading Days after the Company’s receipt by electronic mail
of a copy of a Conversion Notice or an Installment Date if the Company has delivered a Company Installment Notice pursuant to
which a Company Installment Conversion Payment will be made the Company shall fail to issue and deliver a certificate to the Holder
or credit the Holder’s balance account with DTC for the number of shares of Common Stock to which the Holder is entitled
upon such conversion of any Conversion Amount (a “Conversion Failure”), and if on or after such Trading Day
the Holder purchases (in an open market transaction or otherwise) Common Stock to deliver in satisfaction of a sale by the Holder
of Common Stock issuable upon such conversion that the Holder anticipated receiving from the Company (a “Buy-In”),
then the Company shall, within 3 Business Days after the Holder’s request and in the Holder’s discretion, either (i)
pay cash to the Holder in an amount equal to the Holder’s total purchase price (including brokerage commissions and other
out of pocket expenses, if any) for the shares of Common Stock so purchased (the “Buy-In Price”),
at which point the Company’s obligation to deliver such certificate (and to issue such Common Stock) shall terminate, or
(ii) promptly honor its obligation to deliver to the Holder a certificate or certificates representing such Common Stock and pay
cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (A) such number of shares
of Common Stock, times (B) the Closing Bid Price on the Conversion Date.

 

(iii)
Book-Entry. Notwithstanding anything to the contrary set forth herein, upon conversion of any portion of this Debenture
in accordance with the terms hereof, the Holder shall not be required to physically surrender this Debenture to the Company unless
(A) the full Conversion Amount represented by this Debenture is being converted or (B) the Holder has provided the Company with
prior written notice (which notice may be included in a Conversion Notice) requesting reissuance of this Debenture upon physical
surrender of this Debenture. The Holder and the Company shall maintain records showing the Principal and Interest converted and
the dates of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Company, so as not
to require physical surrender of this Debenture upon conversion.

 

    	8

    	 

    

 

(e)
Limitations on Conversions.

 

(i)
Beneficial Ownership. The Company shall not affect any conversions of this Debenture and the Holder shall not have the
right to convert any portion of this Debenture or receive shares of Common Stock as payment of interest hereunder to the extent
that after giving effect to such conversion or receipt of such interest payment, the Holder, together with any affiliate thereof,
would beneficially own (as determined in accordance with Section 13(d) of the Exchange Act and the rules promulgated thereunder)
in excess of 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such conversion or receipt
of shares as payment of interest. Since the Holder will not be obligated to report to the Company the number of shares of Common
Stock it may hold at the time of a conversion hereunder, unless the conversion at issue would result in the issuance of shares
of Common Stock in excess of 4.99% of the then outstanding shares of Common Stock without regard to any other shares which may
be beneficially owned by the Holder or an affiliate thereof, the Holder shall have the authority and obligation to determine whether
the restriction contained in this Section will limit any particular conversion hereunder and to the extent that the Holder determines
that the limitation contained in this Section applies, the determination of which portion of the principal amount of this Debenture
is convertible shall be the responsibility and obligation of the Holder. If the Holder has delivered a Conversion Notice for a
principal amount of this Debenture that, without regard to any other shares that the Holder or its affiliates may beneficially
own, would result in the issuance in excess of the permitted amount hereunder, the Company shall notify the Holder of this fact
and shall honor the conversion for the maximum principal amount permitted to be converted on such Conversion Date in accordance
with Section 4(a) and, any principal amount tendered for conversion in excess of the permitted amount hereunder shall remain outstanding
under this Debenture. The provisions of this Section may be waived by a Holder (but only as to itself and not to any other Holder)
upon not less than 65 days prior notice to the Company. Other Holders shall be unaffected by any such waiver.

 

(f)
Other Provisions.

 

(i)
The Company shall at all times reserve and keep available out of its authorized Common Stock the full number of shares of Common
Stock issuable upon conversion of all outstanding amounts under this Debenture; and within 3 Business Days following the receipt
by the Company of a Holder’s notice that such minimum number of Underlying Shares is not so reserved, the Company shall
promptly reserve a sufficient number of shares of Common Stock to comply with such requirement.

 

(ii)
All calculations under this Section 4 shall be rounded to the nearest $0.0001 or whole share.

 

(iii)
The Company covenants that it will at all times reserve and keep available out of its authorized and unissued shares of Common
Stock solely for the purpose of issuance upon conversion of this Debenture and payment of interest on this Debenture, each as
herein provided, free from preemptive rights or any other actual contingent purchase rights of persons other than the Holder,
not less than such number of shares of the Common Stock as shall (subject to any additional requirements of the Company as to
reservation of such shares set forth in this Debenture or in the Transaction Documents) be issuable (taking into account the adjustments
and restrictions set forth herein) upon the conversion of the outstanding principal amount of this Debenture and payment of interest
hereunder. The Company covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly and validly
authorized, issued and fully paid, nonassessable and, if a registration statement has been declared and remains effective under
the Securities Act, registered for public sale in accordance with such registration statement.

 

    	9

    	 

    

 

(iv)
Nothing herein shall limit a Holder’s right to pursue actual damages or declare an Event of Default pursuant to Section
2 herein for a Conversion Failure and such Holder shall have the right to pursue all remedies available to it at law or in equity
including, without limitation, a decree of specific performance and/or injunctive relief, in each case without the need to post
a bond or provide other security. The exercise of any such rights shall not prohibit the Holder from seeking to enforce damages
pursuant to any other Section hereof or under applicable law.

 

(5)
Purchase Rights.

 

(a)
Purchase Rights. If at any time the Company grants, issues or sells any Options, Convertible Securities or rights to purchase
stock, warrants, securities or other property pro rata to the record holders of any class of Common Stock (the “Purchase
Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate
Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon
complete conversion of this Debenture (without taking into account any limitations or restrictions on the convertibility of this
Debenture) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or,
if no such record is taken, the date as of which the record holders of Common Stock are to be determined for the grant, issue
or sale of such Purchase Rights.

 

(b)
Other Events. If any event occurs of the type contemplated by the provisions of this Section 4 but not expressly provided
for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other
rights with equity features), then the Company’s Board of Directors will make an appropriate adjustment in the Conversion
Price so as to protect the rights of the Holder under this Debenture; provided that no such adjustment will increase the Conversion
Price as otherwise determined pursuant to this Section 5.

 

(c)
Other Corporate Events. In addition to and not in substitution for any other rights hereunder, prior to the consummation
of any Fundamental Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other
assets with respect to or in exchange for shares of Common Stock (a “Corporate Event”), the Company shall make
appropriate provision to insure that the Holder will thereafter have the right to receive upon a conversion of this Debenture,
at the Holder’s option, (i) in addition to the shares of Common Stock receivable upon such conversion, such securities or
other assets to which the Holder would have been entitled with respect to such shares of Common Stock had such shares of Common
Stock been held by the Holder upon the consummation of such Corporate Event (without taking into account any limitations or restrictions
on the convertibility of this Debenture) or (ii) in lieu of the shares of Common Stock otherwise receivable upon such conversion,
such securities or other assets received by the holders of shares of Common Stock in connection with the consummation of such
Corporate Event in such amounts as the Holder would have been entitled to receive had this Debenture initially been issued with
conversion rights for the form of such consideration (as opposed to shares of Common Stock) at a conversion rate for such consideration
commensurate with the Conversion Rate. Provision made pursuant to the preceding sentence shall be in a form and substance satisfactory
to the Required Holders. The provisions of this Section shall apply similarly and equally to successive Corporate Events and shall
be applied without regard to any limitations on the conversion or redemption of this Debenture.

 

    	10

    	 

    

 

(d)
In case of any (1) merger or consolidation of the Company or any subsidiary of the Company with or into another Person, or (2)
sale by the Company or any subsidiary of the Company of more than one-half of the assets of the Company in one or a series of
related transactions, a Holder shall have the right to (A) exercise any rights under Section 2(b), (B) convert the aggregate amount
of this Debenture then outstanding into the shares of stock and other securities, cash and property receivable upon or deemed
to be held by holders of Common Stock following such merger, consolidation or sale, and such Holder shall be entitled upon such
event or series of related events to receive such amount of securities, cash and property as the shares of Common Stock into which
such aggregate principal amount of this Debenture could have been converted immediately prior to such merger, consolidation or
sale would have been entitled, or (C) in the case of a merger or consolidation, require the surviving entity to issue to the Holder
a convertible Debenture with a principal amount equal to the aggregate principal amount of this Debenture then held by such Holder,
plus all accrued and unpaid interest and other amounts owing thereon, which such newly issued convertible Debenture shall have
terms identical (including with respect to conversion) to the terms of this Debenture, and shall be entitled to all of the rights
and privileges of the Holder of this Debenture set forth herein and the agreements pursuant to which this Debentures were issued.
In the case of clause (C), the conversion price applicable for the newly issued shares of convertible preferred stock or convertible
Debentures shall be based upon the amount of securities, cash and property that each share of Common Stock would receive in such
transaction and the Market Conversion Price, (in the event a conversion utilizing the Market Conversion Price hereunder is pending),
as applicable, in effect immediately prior to the effectiveness or closing date for such transaction. The terms of any such merger,
sale or consolidation shall include such terms so as to continue to give the Holder the right to receive the securities, cash
and property set forth in this Section upon any conversion or redemption following such event. This provision shall similarly
apply to successive such events.

 

(6)
REISSUANCE OF THIS DEBENTURE.

 

(a)
Transfer. If this Debenture is to be transferred, the Holder shall surrender this Debenture to the Company, whereupon the
Company will, subject to the satisfaction of the transfer provisions of the Securities Purchase Agreement, forthwith issue and
deliver upon the order of the Holder a new Debenture (in accordance with Section 6(d)), registered in the name of the registered
transferee or assignee, representing the outstanding Principal being transferred by the Holder and, if less than the entire outstanding
Principal is being transferred, a new Debenture (in accordance with Section 6(d)) to the Holder representing the outstanding Principal
not being transferred. The Holder and any assignee, by acceptance of this Debenture, acknowledge and agree that, by reason of
the provisions of Section 4(b)(iii) following conversion or redemption of any portion of this Debenture, the outstanding Principal
represented by this Debenture may be less than the Principal stated on the face of this Debenture.

 

    	11

    	 

    

 

(b)
Lost, Stolen or Mutilated Debenture. Upon receipt by the Company of evidence reasonably satisfactory to the Company of
the loss, theft, destruction or mutilation of this Debenture, and, in the case of loss, theft or destruction, of any indemnification
undertaking by the Holder to the Company in customary form and, in the case of mutilation, upon surrender and cancellation of
this Debenture, the Company shall execute and deliver to the Holder a new Debenture (in accordance with Section 6(d)) representing
the outstanding Principal.

 

(c)
Debenture Exchangeable for Different Denominations. This Debenture is exchangeable, upon the surrender hereof by the Holder
at the principal office of the Company, for a new Debenture or Debentures (in accordance with Section 6(d)) representing in the
aggregate the outstanding Principal of this Debenture, and each such new Debenture will represent such portion of such outstanding
Principal as is designated by the Holder at the time of such surrender.

 

(d)
Issuance of New Debentures. Whenever the Company is required to issue a new Debenture pursuant to the terms of this Debenture,
such new Debenture (i) shall be of like tenor with this Debenture, (ii) shall represent, as indicated on the face of such new
Debenture, the Principal remaining outstanding (or in the case of a new Debenture being issued pursuant to Section 6(a) or Section
6(c), the Principal designated by the Holder which, when added to the principal represented by the other new Debentures issued
in connection with such issuance, does not exceed the Principal remaining outstanding under this Debenture immediately prior to
such issuance of new Debentures), (iii) shall have an issuance date, as indicated on the face of such new Debenture, which is
the same as the Issuance Date of this Debenture, (iv) shall have the same rights and conditions as this Debenture, and (v) shall
represent accrued and unpaid Interest from the Issuance Date.

 

    	12

    	 

    

 

(7)
NOTICES. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this
Agreement must be in writing and will be deemed to have been delivered upon: (i) receipt, when delivered personally, (ii) 1 Business
Day after deposit with an overnight courier service with next day delivery specified, in each case, properly addressed to the
party to receive the same, or (iii) receipt, when sent by electronic mail (provided that the electronic mail transmission is not
returned in error or the sender is not otherwise notified of any error in transmission. The addresses and e-mail addresses for
such communications shall be:

 

	If
    to the Company, to:	Kraig
    Biocraft Laboratories, Inc.
	 	2723
    South State Street – Suite 150
	 	Ann
    Arbor, MI 48104
	 	Attention:	Kim
    Thompson
	 	Telephone:	(734)
    619-8066
	 	Email:	 
	 	 	 
	With
    a copy to:	Hunter
    Taubman Fischer & Li LLC
	 	800 Third Avenue, Suite 2800
	 	New York, NY 10023
	 	Attention:	Louis
    Taubman, Esq.
	 	Telephone:	(917)512-0827
	 	Email:	ltaubman@htflawyers.com

 

	If
    to the Holder:	YAII
    PN, Ltd.  
	 	 
	With
    a copy to:	David
    Gonzalez, Esq.
	 	1012
    Springfield Avenue
	 	Mountainside,
    NJ 07092
	 	Telephone:	(201)
    536-5109
	 	Email:	 

 

or
at such other address and/or electronic email address and/or to the attention of such other person as the recipient party has
specified by written notice given to each other party 3 Business Days prior to the effectiveness of such change. Written confirmation
of receipt (i) given by the recipient of such notice, consent, waiver or other communication, (ii) mechanically or electronically
generated by the sender’s computer containing the time, date, recipient’s electronic mail address and the text of
such electronic mail or (iii) provided by a nationally recognized overnight delivery service, shall be rebuttable evidence of
personal service, receipt by electronic mail or receipt from a nationally recognized overnight delivery service in accordance
with clause (i), (ii) or (iii) above, respectively.

 

    	13

    	 

    

 

(8)
Except as expressly provided herein, no provision of this Debenture shall alter or impair the obligations of the Company, which
are absolute and unconditional, to pay the principal of, interest and other charges (if any) on, this Debenture at the time, place,
and rate, and in the coin or currency, herein prescribed. This Debenture is a direct obligation of the Company. As long as this
Debenture is outstanding, the Company shall not and shall cause their subsidiaries not to, without the consent of the Holder,
(i) amend its certificate of incorporation, bylaws or other charter documents so as to adversely affect any rights of the Holder
(which shall include combining (by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares);
(ii) repay, repurchase or offer to repay, repurchase or otherwise acquire shares of its Common Stock or other equity securities
other than as to the Underlying Shares to the extent permitted or required under the Transaction Documents; or (iii) enter into
any agreement with respect to any of the foregoing. Notwithstanding the foregoing, the Company shall be permitted to affect a
reverse stock split in order to comply with the initial listing requirements of Nasdaq.

 

(9)
This Debenture shall not entitle the Holder to any of the rights of a stockholder of the Company, including without limitation,
the right to vote, to receive dividends and other distributions, or to receive any notice of, or to attend, meetings of stockholders
or any other proceedings of the Company, unless and to the extent converted into shares of Common Stock in accordance with the
terms hereof.

 

(10)
No indebtedness of the Company is senior to this Debenture in right of payment, whether with respect to interest, damages or upon
liquidation or dissolution or otherwise. Without the Holder’s consent, the Company will not and will not permit any of their
subsidiaries to, directly or indirectly, enter into, create, incur, assume or suffer to exist any indebtedness of any kind, on
or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits
there from that is senior in any respect to the obligations of the Company under this Debenture.

 

(11)
This Debenture shall be governed by and construed in accordance with the laws of the State of New Jersey, without giving effect
to conflicts of laws thereof. Each of the parties consents to the jurisdiction of the Superior Courts of the State of New Jersey
sitting in Union County, New Jersey and the U.S. District Court for the District of New Jersey sitting in Newark, New Jersey in
connection with any dispute arising under this Debenture and hereby waives, to the maximum extent permitted by law, any objection,
including any objection based on forum non conveniens to the bringing of any such proceeding in such jurisdictions.

 

(12)
If the Company fails to strictly comply with the terms of this Debenture, then the Company shall reimburse the Holder promptly
for all fees, costs and expenses, including, without limitation, attorneys’ fees and expenses incurred by the Holder in
any action in connection with this Debenture, including, without limitation, those incurred: (i) during any workout, attempted
workout, and/or in connection with the rendering of legal advice as to the Holder’s rights, remedies and obligations, (ii)
collecting any sums which become due to the Holder, (iii) defending or prosecuting any proceeding or any counterclaim to any proceeding
or appeal; or (iv) the protection, preservation or enforcement of any rights or remedies of the Holder.

 

    	14

    	 

    

 

(13)
Any waiver by the Holder of a breach of any provision of this Debenture shall not operate as or be construed to be a waiver of
any other breach of such provision or of any breach of any other provision of this Debenture. The failure of the Holder to insist
upon strict adherence to any term of this Debenture on one or more occasions shall not be considered a waiver or deprive that
party of the right thereafter to insist upon strict adherence to that term or any other term of this Debenture. Any waiver must
be in writing.

 

(14)
If any provision of this Debenture is invalid, illegal or unenforceable, the balance of this Debenture shall remain in effect,
and if any provision is inapplicable to any person or circumstance, it shall nevertheless remain applicable to all other persons
and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder shall violate applicable
laws governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum permitted
rate of interest. The Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon,
plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law or other law which
would prohibit or forgive the Company from paying all or any portion of the principal of or interest on this Debenture as contemplated
herein, wherever enacted, now or at any time hereafter in force, or which may affect the covenants or the performance of this
indenture, and the Company (to the extent it may lawfully do so) hereby expressly waives all benefits or advantage of any such
law, and covenants that it will not, by resort to any such law, hinder, delay or impeded the execution of any power herein granted
to the Holder, but will suffer and permit the execution of every such as though no such law has been enacted.

 

(15)
Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made
on the next succeeding Business Day.

 

(16)
THE PARTIES HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVE THE RIGHT ANY OF THEM MAY HAVE TO A TRIAL BY JURY IN RESPECT
OF ANY LITIGATION BASED HEREON OR ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY TRANSACTION DOCUMENT OR ANY
COURSE OF CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ACTIONS OF ANY PARTY. THIS PROVISION IS A MATERIAL
INDUCEMENT FOR THE PARTIES’ ACCEPTANCE OF THIS AGREEMENT.

 

(17)
CERTAIN DEFINITIONS For purposes of this Debenture, the following terms shall have the following meanings:

 

(a)
“Approved Stock Plan” means a stock plan, that has been approved by the Board of Directors of the Company,
pursuant to which the Company’s securities may be issued only to any employee, officer, or director or third party service
providers in the normal course of business, for services provided to the Company.

 

    	15

    	 

    

 

(b)
“Bloomberg” means Bloomberg Financial Markets.

 

(c)
“Business Day” means any day except Saturday, Sunday and any day which shall be a federal legal holiday in
the United States or a day on which banking institutions are authorized or required by law or other government action to close.

 

(d)
“Cash Payment Premium” means with regard to any Installment Amount being paid in cash an amount equal to an
amount equal to 10% of the of the Installment Amount for Installment Amounts due within 180 days following the Closing, and 15%
of the Installment Amount for Installment Amounts due thereafter.

 

(e)
“Change of Control Transaction” means the occurrence of (a) an acquisition after the date hereof by an individual
or legal entity or “group” (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective control
(whether through legal or beneficial ownership of capital stock of the Company, by contract or otherwise) of in excess of fifty
percent (50%) of the voting securities of the Company (except that the acquisition of voting securities by the Holder or any other
current holder of convertible securities of the Company shall not constitute a Change of Control Transaction for purposes hereof),
(b) a replacement at one time or over time of more than one-half of the members of the board of directors of the Company which
is not approved by a majority of those individuals who are members of the board of directors on the date hereof (or by those individuals
who are serving as members of the board of directors on any date whose nomination to the board of directors was approved by a
majority of the members of the board of directors who are members on the date hereof), (c) the merger, consolidation or sale of
fifty percent (50%) or more of the assets of the Company or any subsidiary of the Company in one or a series of related transactions
with or into another entity, or (d) the execution by the Company of an agreement to which the Company is a party or by which it
is bound, providing for any of the events set forth above in (a), (b) or (c).

 

(f)
“Closing Bid Price” means the price per share in the last reported trade of the Common Stock on a Primary Market
or on the exchange on which the Common Stock is then listed as quoted by Bloomberg.

 

(g)
“Convertible Securities” means any stock or securities (other than Options) directly or indirectly convertible
into or exercisable or exchangeable for Common Stock.

 

(h)
“Commission” means the Securities and Exchange Commission.

 

(i)
“Common Stock” means the Class A common stock, no par value, of the Company and stock of any other class into
which such shares may hereafter be changed or reclassified.

 

    	16

    	 

    

 

(j)
“Equity Conditions” means that each of the following conditions is satisfied: (i) on each day during the period
beginning 2 weeks prior to the applicable date of determination and ending on and including the applicable date of determination
(the “Equity Conditions Measuring Period”), all applicable shares of Common Stock to be issued in connection
with the event requiring determination shall be eligible for sale without restriction and without the need for registration under
any applicable federal or state securities laws; (ii) on each day during the Equity Conditions Measuring Period, the Common Stock
is designated for quotation on the Principal Market and shall not have been suspended from trading on such exchange or market
nor shall delisting or suspension by such exchange or market been threatened or pending either (A) in writing by such exchange
or Principal Market or (B) by falling below the then effective minimum listing maintenance requirements of such exchange or Principal
Market; (iii) during the Equity Conditions Measuring Period, the Company shall have delivered Conversion Shares with respect to
any prior conversions of the Debenture, if any, to the Holder on a timely basis as set forth in Section 4(e)(ii) hereof; (iv)
any applicable shares of Common Stock to be issued in connection with the event requiring determination may be issued in full
without violating Section 4(f) hereof and the rules or regulations of the Primary Market; (v) during the Equity Conditions Measuring
Period, there shall not have occurred either (A) an Event of Default or (B) an event that with the passage of time or giving of
notice would constitute an Event of Default; and (vii) the Company shall have no knowledge of any fact that would cause any applicable
shares of Common Stock to be issued in connection with the event requiring determination not to be eligible for sale without restriction
and without the need for registration under any applicable federal or state securities laws.

 

(k)
“Equity Conditions Failure” means that on any applicable date the Equity Conditions have not been satisfied
(or waived in writing by the Holder).

 

(l)
“Exchange Act” means the Securities Exchange Act of 1934, as amended.

 

(m)
“Excluded Securities” means, (a) shares issued or deemed to have been issued by the Company pursuant to an
Approved Stock Plan, (b) warrants and options existing and issued as of the Issuance Date and shares issued pursuant to the exercise
of said warrants and option, (c) the shares of Common Stock issued or deemed to be issued by the Company upon conversion of this
Debenture or the Warrant issued pursuant to the Securities Purchase Agreement, (d) shares of Common Stock or other securities
issued in connection with a strategic acquisition, intellectual property licensing agreement or other similar transaction not
initiated for the purpose of capital raising and (e) any securities of the Company registered in registration statement No. 333-238883
currently on file with the SEC.

 

(n)
“Installment Amount” means with respect to any Installment Date, $166,666 (the last payment being 166,670)
of Principal amount of this Debenture, plus accrued and outstanding Interest. In the event the Holder shall sell or otherwise
transfer any portion of this Debenture, the transferee shall be allocated a pro rata portion of each unpaid Installment Amount
hereunder. In the event that the Holder is the holder of more than one Debenture of this series of Secured Convertible Debentures
issued pursuant to the Securities Purchase Agreement, then the Holder shall have the right to allocate the total Installment Amount
due to it among the Debentures as it sees fit and shall notify the Company of such allocation.

 

(o)
“Installment Date” Commencing on July 1, 2021, and the 1st Business Day of each successive calendar month thereafter
until all Principal Amount and outstanding and accrued Interest owed and outstanding hereunder has been paid.

 

(p)
“Options” means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible
Securities.

 

    	17

    	 

    

 

(q)
“Issuance Date” means the date of the first issuance of this Debenture regardless of the number of transfers
and regardless of the number of instruments, which may be issued to evidence such Debenture.

 

(r)
“Person” means a corporation, an association, a partnership, organization, a business, an individual, a government
or political subdivision thereof or a governmental agency.

 

(s)
“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

(t)
“Securities Purchase Agreement” means the Securities Purchase Agreement dated the date hereof by and among
the Company and the Investor.

 

(u)
“Trading Day” means a day on which the shares of Common Stock are quoted on the Primary Market on which the
shares of Common Stock are then quoted or listed; provided, that in the event that the shares of Common Stock are not listed or
quoted, then Trading Day shall mean a Business Day.

 

(v)
“Transaction Documents” means the Securities Purchase Agreement or any other agreement delivered in connection
with the Securities Purchase Agreement, including, without limitation, the Irrevocable Transfer Agent Instructions, and the Warrant.

 

(w)
“Underlying Shares” means the shares of Common Stock issuable upon conversion of this Debenture or as payment
of interest in accordance with the terms hereof.

 

(x)
“VWAP” means, for any security as of any date, the daily dollar volume-weighted average price for such security
as reported by Bloomberg, LP through its “Historical Price Table Screen (HP)” with Market: Weighted Ave function selected,
or, if no dollar volume-weighted average price is reported for such security by Bloomberg, the average of the highest closing
bid price and the lowest closing ask price of any of the market makers for such security as reported in the “pink sheets”
by Pink Sheets LLC.

 

(y)
“Warrant” has the meaning ascribed to such term in the Securities Purchase Agreement, and shall include all
warrants issued in exchange therefor or replacement thereof.

 

[Signature
Page Follows]

 

    	18

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Convertible Debenture to be duly executed by a duly authorized officer as of
the date set forth above.

 

 

	 	COMPANY:
	 	KRAIG
    BIOCRAFT LABORATORIES, INC.
	 	 	 
	 	By:	                         
	 	Name:	 
	 	Title:	 

 

    	 

    	 

    

 

EXHIBIT
I

CONVERSION
NOTICE

 

(To
be executed by the Holder in order to Convert the Debenture)

 

	TO:
    

 

The
undersigned hereby irrevocably elects to convert $____________________________ of the principal amount of Debenture No. KBLB-1-1
into Shares of Common Stock of KRAIG BIOCRAFT LABORATORIES, INC., according to the conditions stated therein, as of the
Conversion Date written below.

 

	Conversion
    Date:	 	 
	Conversion
    Amount to be converted:	$	
	Conversion
    Price:	$	
	Number
    of shares of Common Stock to be issued:	 	 
	Amount
    of Debenture Unconverted:	$	
	 	 	 
	Please
    issue the shares of Common Stock in the following name and to the following address:
	Issue
    to:	 	 

         

         

	 	 	 
	Authorized
    Signature:	 	 
	Name:	 	 
	Title:	 	 
	Broker
    DTC Participant Code:	 	 
	Account
    Number:	 	 

 

    	 

    	 

    

 

EXHIBIT
II

 

PAYMENT
SCHEDULE

 

	Installment Date	 	Amount Outstanding	 	 	Installment Amount	 	 	15% Cash Payment Premium	 	 	10% 
Interest on Amount
    Outstanding	 	 	Total Payment Amount	 
	7/1/2021	 	$	1,000,000.00	 	 	$	166,666.00	 	 	$	24,999.90	 	 	$	55,890.41	 	 	$	247,556.31	 
	8/1/2021	 	$	833,334.00	 	 	$	166,666.00	 	 	$	24,999.90	 	 	$	7,077.63	 	 	$	198,743.53	 
	9/1/2021	 	$	666,668.00	 	 	$	166,666.00	 	 	$	24,999.90	 	 	$	5,662.11	 	 	$	197,328.01	 
	10/1/2021	 	$	500,002.00	 	 	$	166,666.00	 	 	$	24,999.90	 	 	$	4,109.61	 	 	$	195,775.51	 
	11/1/2021	 	$	333,336.00	 	 	$	166,666.00	 	 	$	24,999.90	 	 	$	2,831.07	 	 	$	194,496.97	 
	12/1/2021	 	$	166,670.00	 	 	$	166,670.00	 	 	$	25,000.50	 	 	$	1,369.89	 	 	$	193,040.39	 
	 	 	 	 	 	 	$	1,000,000.00	 	 	$	150,000.00	 	 	$	76,940.72	 	 	$	1,226,940.72	 

 

    	 

    	 

    

 

EXHIBIT
III

 

INVESTOR
WIRING INSTRUCTIONS

 

*Account
Currency: USD

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]